Core Scientific Financial Statements
NASDAQ: CORZFinanceFinance: Consumer ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Core Scientific revenue and earnings
In fiscal 2025, Core Scientific generated $319.0 million in revenue, down 37.5% from fiscal 2024, its first annual decline since 2023. Core Scientific reported a net loss of $288.6 million, compared with a loss of $1.44 billion a year earlier. Gross margin was 11.9% (down from 23.7%) and operating margin -77.0%.
Diluted earnings per share came in at -$0.88. Over the last 5 fiscal years, CORZ's revenue has grown at a 39.5% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Core Scientific income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 319.02M | 510.67M | 502.40M | 640.31M | 544.48M | 60.32M |
| Revenue growth (YoY) | -37.53% | +1.65% | -21.54% | +17.60% | +802.66% | — |
| Cost of Revenue | 281.12M | 389.60M | 378.94M | 631.91M | 305.62M | 50.93M |
| Gross Profit | 37.90M | 121.07M | 123.46M | 8.40M | 238.86M | 9.39M |
| Operating Expenses | 283.49M | 263.13M | 114.50M | 252.97M | 72.22M | 21.60M |
| Research & Development | — | 11.83M | 7.18M | 26.96M | 7.67M | 5.27M |
| Selling, General & Admin | 159.22M | 113.69M | 108.11M | 226.01M | 64.55M | 16.32M |
| Operating Income | -245.59M | -142.06M | 8.96M | -2.11B | 131.49M | -6.33M |
| Other Income (Expense) | -42.44M | -1.29B | -254.76M | -53.86M | -68.42M | -5.88M |
| Pretax Income | -288.03M | -1.44B | -245.80M | -2.16B | 63.08M | -12.21M |
| Income Tax | 583.00K | 859.00K | 683.00K | -17.09M | 15.76M | 0 |
| Net Income | -288.62M | -1.44B | -246.49M | -2.15B | 47.31M | -12.21M |
| Net Income growth (YoY) | — | — | — | -4636.52% | — | — |
| EPS (Basic) | -0.88 | -4.87 | -0.65 | -6.30 | 0.23 | -0.14 |
| EPS (Diluted) | -0.88 | -4.87 | -0.65 | -6.30 | 0.20 | -0.14 |
| Shares Outstanding (Basic) | 318.07M | 255.83M | 379.86M | 340.65M | 207.26M | 157.60M |
| Shares Outstanding (Diluted) | 318.07M | 255.83M | 379.86M | 340.65M | 233.31M | 157.60M |
| EBITDA | -176.68M | -28.86M | 104.96M | -1.88B | 164.86M | 3.08M |
| Gross Margin | 11.88% | 23.71% | 24.57% | 131.00% | 43.87% | 15.57% |
| Operating Margin | -76.98% | -27.82% | 1.78% | -329.46% | 24.15% | -10.49% |
| Net Margin | -90.47% | -281.57% | -49.06% | -335.20% | 8.69% | -20.24% |
This table shows 6 annual periods of Core Scientific's income statement, from FY 2025 back to FY 2020, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow CORZ's reporting calendar. What is a income statement?